Cargando…
SGOL1-AS1 enhances cell survival in acute myeloid leukemia by maintaining pro-inflammatory signaling
Epigenetic dysregulation is a key feature of most acute myeloid leukemia (AML). Recently, it has become clear that long noncoding RNAs (lncRNAs) can play a key role in epigenetic regulation, and consequently also dysregulation. Currently, our understanding of the requirements and roles of lncRNAs in...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663857/ https://www.ncbi.nlm.nih.gov/pubmed/36387443 http://dx.doi.org/10.1016/j.heliyon.2022.e11362 |
_version_ | 1784830974328045568 |
---|---|
author | Selkirk, Ewan Patel, Rahima Hoyle, Anna Lie-a-Ling, Michael Smith, Duncan Swift, Joe Lacaud, Georges |
author_facet | Selkirk, Ewan Patel, Rahima Hoyle, Anna Lie-a-Ling, Michael Smith, Duncan Swift, Joe Lacaud, Georges |
author_sort | Selkirk, Ewan |
collection | PubMed |
description | Epigenetic dysregulation is a key feature of most acute myeloid leukemia (AML). Recently, it has become clear that long noncoding RNAs (lncRNAs) can play a key role in epigenetic regulation, and consequently also dysregulation. Currently, our understanding of the requirements and roles of lncRNAs in AML is still limited. Here, using CRISPRi screening, we identified the lncRNA SGOL1-AS1 as an essential regulator of survival in THP-1 AML cells. We demonstrated that SGOL1-AS1 interacts with chromatin-modifying proteins involved in gene repression and that SGOL1-AS1 knockdown is associated with increased heterochromatin formation. We also observed that loss of SGOLl-AS1 results in increased apoptosis and the downregulation of pro-inflammatory genes. In AML patients, high expression of SGOL1-AS1 correlates with both pro-inflammatory gene expression and poor survival. Altogether, our data reveal that SGOL1-AS1 is an essential regulator of cell survival in AML cell lines and a possible regulator of pro-inflammatory signaling in AML patients. |
format | Online Article Text |
id | pubmed-9663857 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-96638572022-11-15 SGOL1-AS1 enhances cell survival in acute myeloid leukemia by maintaining pro-inflammatory signaling Selkirk, Ewan Patel, Rahima Hoyle, Anna Lie-a-Ling, Michael Smith, Duncan Swift, Joe Lacaud, Georges Heliyon Research Article Epigenetic dysregulation is a key feature of most acute myeloid leukemia (AML). Recently, it has become clear that long noncoding RNAs (lncRNAs) can play a key role in epigenetic regulation, and consequently also dysregulation. Currently, our understanding of the requirements and roles of lncRNAs in AML is still limited. Here, using CRISPRi screening, we identified the lncRNA SGOL1-AS1 as an essential regulator of survival in THP-1 AML cells. We demonstrated that SGOL1-AS1 interacts with chromatin-modifying proteins involved in gene repression and that SGOL1-AS1 knockdown is associated with increased heterochromatin formation. We also observed that loss of SGOLl-AS1 results in increased apoptosis and the downregulation of pro-inflammatory genes. In AML patients, high expression of SGOL1-AS1 correlates with both pro-inflammatory gene expression and poor survival. Altogether, our data reveal that SGOL1-AS1 is an essential regulator of cell survival in AML cell lines and a possible regulator of pro-inflammatory signaling in AML patients. Elsevier 2022-11-05 /pmc/articles/PMC9663857/ /pubmed/36387443 http://dx.doi.org/10.1016/j.heliyon.2022.e11362 Text en © 2022 Published by Elsevier Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research Article Selkirk, Ewan Patel, Rahima Hoyle, Anna Lie-a-Ling, Michael Smith, Duncan Swift, Joe Lacaud, Georges SGOL1-AS1 enhances cell survival in acute myeloid leukemia by maintaining pro-inflammatory signaling |
title | SGOL1-AS1 enhances cell survival in acute myeloid leukemia by maintaining pro-inflammatory signaling |
title_full | SGOL1-AS1 enhances cell survival in acute myeloid leukemia by maintaining pro-inflammatory signaling |
title_fullStr | SGOL1-AS1 enhances cell survival in acute myeloid leukemia by maintaining pro-inflammatory signaling |
title_full_unstemmed | SGOL1-AS1 enhances cell survival in acute myeloid leukemia by maintaining pro-inflammatory signaling |
title_short | SGOL1-AS1 enhances cell survival in acute myeloid leukemia by maintaining pro-inflammatory signaling |
title_sort | sgol1-as1 enhances cell survival in acute myeloid leukemia by maintaining pro-inflammatory signaling |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663857/ https://www.ncbi.nlm.nih.gov/pubmed/36387443 http://dx.doi.org/10.1016/j.heliyon.2022.e11362 |
work_keys_str_mv | AT selkirkewan sgol1as1enhancescellsurvivalinacutemyeloidleukemiabymaintainingproinflammatorysignaling AT patelrahima sgol1as1enhancescellsurvivalinacutemyeloidleukemiabymaintainingproinflammatorysignaling AT hoyleanna sgol1as1enhancescellsurvivalinacutemyeloidleukemiabymaintainingproinflammatorysignaling AT liealingmichael sgol1as1enhancescellsurvivalinacutemyeloidleukemiabymaintainingproinflammatorysignaling AT smithduncan sgol1as1enhancescellsurvivalinacutemyeloidleukemiabymaintainingproinflammatorysignaling AT swiftjoe sgol1as1enhancescellsurvivalinacutemyeloidleukemiabymaintainingproinflammatorysignaling AT lacaudgeorges sgol1as1enhancescellsurvivalinacutemyeloidleukemiabymaintainingproinflammatorysignaling |